Skip to main content
Year archive

U2BIO CO., LTD. — 2022 filings

All 19 regulatory filings released by U2BIO CO., LTD. (221800) in 2022, sourced directly from the official regulator.

19 Filings
2022 Period
2022 filings (19)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-14 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2022-12-14 Korean
기업설명회(IR)개최결과
Regulatory Filings
2022-11-25 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-11-09 Korean
본점소재지변경
Regulatory Filings
2022-06-24 Korean
[기재정정]감사보고서제출(2019사업연도)
Audit Report / Information FY 2019
2022-06-03 Korean
[기재정정]감사보고서제출(2020사업연도)
Audit Report / Information FY 2020
2022-06-03 Korean
[기재정정]사업보고서 (2019.12)
Audit Report / Information FY 2019
2022-06-03 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2022-06-03 Korean
기업설명회(IR)개최결과
Regulatory Filings
2022-05-17 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-05-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-29 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-21 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2022-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-14 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-14 Korean